Singapore markets closed

Humana Inc. (HUM)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
391.66-1.93 (-0.49%)
At close: 04:03PM EST
384.70 -6.96 (-1.78%)
Pre-market: 04:50AM EST
Full screen
Trade prices are not sourced from all markets
Previous close393.59
Bid0.00 x 800
Ask0.00 x 1200
Day's range386.75 - 399.90
52-week range351.20 - 475.44
Avg. volume980,300
Market cap50.342B
Beta (5Y monthly)0.94
PE ratio (TTM)19.10
EPS (TTM)20.51
Earnings date02 Feb 2022
Forward dividend & yield2.80 (0.71%)
Ex-dividend date30 Dec 2021
1y target est485.87
  • Business Wire

    Humana Names Dr. Andrew Agwunobi President of Company’s Home Solutions Business

    LOUISVILLE, Ky., January 14, 2022--Leading health insurer and health care services company Humana Inc. (NYSE: HUM) has hired health care industry veteran Andrew (Andy) Agwunobi, M.D., MBA, as the new President of the company’s Home Solutions business. Dr. Agwunobi comes to Humana from the University of Connecticut, where he currently serves as interim University President, and as CEO of the UConn Health System. In his new role, Dr. Agwunobi will report directly to Humana President and CEO Bruce

  • Zacks

    Humana (HUM) to Buy Back Shares of $1B to Add Shareholder Value

    Humana (HUM) to buy back shares worth $1 billion as part of its $3-billion share repurchase plan announced in February 2021. This suggests its commitment toward delivering a long-term shareholder value.

  • Business Wire

    Humana Inc. to Release Fourth Quarter 2021 Results on February 2, 2022

    LOUISVILLE, Ky., January 13, 2022--Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2021 (4Q21) on Wednesday, February 2, 2022 at 6:30 a.m. Eastern time. The company will host a conference call at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2022.